{"id":30700,"date":"2026-07-07T04:18:00","date_gmt":"2026-07-06T20:18:00","guid":{"rendered":"https:\/\/csccm.org.cn\/?p=30700"},"modified":"2026-07-07T05:56:35","modified_gmt":"2026-07-06T21:56:35","slug":"jama-netw-open%e5%8f%91%e8%a1%a8%e8%ae%ba%e6%96%87%ef%bc%9a%e9%ab%98%e8%85%ba%e7%98%a4%e6%a3%80%e5%87%ba%e7%8e%87%e5%9c%ba%e6%99%af%e4%b8%8b%e5%af%b9%e9%ab%98%e5%8d%b1%e4%ba%ba%e7%be%a4%e7%9a%84","status":"publish","type":"post","link":"https:\/\/csccm.org.cn\/?p=30700","title":{"rendered":"[JAMA Netw Open\u53d1\u8868\u8bba\u6587]\uff1a\u9ad8\u817a\u7624\u68c0\u51fa\u7387\u573a\u666f\u4e0b\u5bf9\u9ad8\u5371\u4eba\u7fa4\u7684\u8ba1\u7b97\u673a\u8f85\u52a9\u7ed3\u80a0\u955c\u68c0\u67e5"},"content":{"rendered":"\n<p>Original Investigation&nbsp;<\/p>\n\n\n\n<p>Gastroenterology and Hepatology<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Computer-Assisted Colonoscopy in High\u2013Adenoma Detection Rate Settings in a High-Risk Population: A Randomized Clinical Trial<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\">Wen-Feng\u00a0Hsu,\u00a0Chen-Ya\u00a0Kuo,\u00a0Hsu-Heng\u00a0Yen,\u00a0et al<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\">JAMA Netw Open 2026;9;(4):e264881.\u00a0doi:10.1001\/jamanetworkopen.2026.4881<\/h3>\n\n\n\n<p>Key Points<\/p>\n\n\n\n<p><strong>Question<\/strong>&nbsp;&nbsp;Does the use of computer-aided detection (CAD) during colonoscopy improve adenoma detection within high\u2013adenoma detection rate (ADR) settings in the context of fecal immunochemical test (FIT)\u2013based screening?<\/p>\n\n\n\n<p><strong>Findings<\/strong>&nbsp;&nbsp;In this randomized clinical trial of 1356 participants, CAD met noninferiority criteria for ADR. Significant increases occurred only in the exploratory FIT-positive subgroup, driven by detection of diminutive adenomas, and led to more intensive surveillance intervals based on US Multi-Society Task Force guidelines.<\/p>\n\n\n\n<p><strong>Meaning<\/strong>&nbsp;&nbsp;CAD-assisted colonoscopy was noninferior to standard colonoscopy; however, detection gains involved mainly small lesions and increased intensive surveillance recommendations, while long-term clinical benefits remain uncertain.<a><\/a><\/p>\n\n\n\n<p>Abstract<\/p>\n\n\n\n<p><strong>Importance<\/strong>\u00a0\u00a0Computer-aided detection (CAD) systems can enhance adenoma detection, but their effectiveness in high-performance settings and among patients with positive fecal immunochemical test (FIT) results remains uncertain.<\/p>\n\n\n\n<p><strong>Objective<\/strong>&nbsp;&nbsp;To evaluate the impact of CAD on adenoma detection in routine practice, focusing on patients with positive FIT results.<\/p>\n\n\n\n<p><strong>Design, Setting, and Participants<\/strong>&nbsp;&nbsp;This multicenter, open-label, randomized clinical trial was conducted at 4 tertiary hospitals in Taiwan from February 23, 2022, to November 27, 2024. Adults aged 40 to 79 years who were scheduled for a colonoscopy owing to FIT positivity, symptoms, screening, or surveillance were randomized 1:1 to CAD-assisted or standard colonoscopy. Data were analyzed from December 1, 2024, to February 28, 2025.<\/p>\n\n\n\n<p><strong>Exposures<\/strong>&nbsp;&nbsp;Colonoscopy performed with a real-time CAD system or standard high-definition colonoscopy.<\/p>\n\n\n\n<p><strong>Main Outcomes and Measures<\/strong>&nbsp;&nbsp;The primary outcome was adenoma detection rate (ADR), defined as the proportion of patients with at least 1 histologically confirmed adenoma. Secondary outcomes included adenomas per colonoscopy (APC), sessile serrated lesion detection rate (SSLDR), and postpolypectomy surveillance intervals according to the US Multi-Society Task Force (USMSTF) and European Society of Gastrointestinal Endoscopy criteria.<\/p>\n\n\n\n<p><strong>Results<\/strong>\u00a0\u00a0Of 1356 randomized participants (mean [SD] age, 60.0 [9.4] years; 678 [50.0%] female and 678 [50.0%] male), CAD-assisted colonoscopy met noninferiority criteria for ADR compared with standard colonoscopy (395 of 675 [58.5%] vs 363 of 681 [53.3%]; absolute difference, 5.2 percentage points [95% CI, \u22120.1 to 10.5 percentage points]). Superiority was not statistically significant. CAD significantly increased mean (SD) APC (1.41 [1.95] vs 1.20 [1.88];\u00a0<em>P<\/em>\u2009=\u2009.01), driven mainly by detection of diminutive adenomas. In exploratory analyses of 864 patients with FIT-positive findings, CAD significantly increased ADR (288 of 441 [65.3%] vs 243 of 423 [57.4%];\u00a0<em>P<\/em>\u2009=\u2009.02; adjusted odds ratio [AOR],\u20091.39 [95% CI, 1.05-1.86]) and APC (mean [SD], 1.64 [2.08] vs 1.39 [2.09];\u00a0<em>P<\/em>\u2009=\u2009.01). SSLDR did not differ between groups. Consequently, CAD led to more intensive surveillance recommendations under USMSTF criteria, particularly in patients with FIT-positive findings (58 of 441 [13.2%] vs 31 of 423 [7.3%]; AOR,\u20091.94 [95% CI, 1.22-3.09]).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939815\/zoi260177va_1775667484.03403.png?Expires=1779317431&amp;Signature=vbTbSTtVSPq1AGIMA8MuFv2WkBL71dbbAgMjsOgaRvx0hsgA0bJDZ5urpe3r70locIfTQ7jNKj94RzWMBpjuXh1X5ciliUEPNrmw6wSWLJWn-rMQTaauBSJV0zYxGvf03ZO-8CNPK6avSDITFgFdK8xFpuCtiY4TGizaCZj59v6Oeq7ThkWR2-fm~rKcMxlkhrlIk6QuVBwF7FH4naY~WvNNJlxsFpwgx2euU4JXxvD-fH0DRszfwgeXAMKmVYllFxEcDnO85EmKYVFVuZYsgJug0P8H8IGOLQGHHT7-4YUtJxjLYWXubJuGvAL0WwNqqIkYWZjw35wV0RiN80fqtw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939815\/zoi260177f1_1775667484.06403.png?Expires=1779317431&amp;Signature=drYxM0wt~pOIV3BWzWWd6RE1XKMH7tz2ZEQdQnluVWbJp8Rl7gtBp9QOTvdFluUCfO~RZ0v91HI0u34p-~LgZO~OeLuUxhwU2rxTv2HyZI692AX32LUndR-hKLkmRJTIX37uTFINdV3oTyzh80TSXtoECUU5rcRmyB5Rlsq6no6hfqEkbVwVnvBhjpybI9q3~1~05bXpSGIi5d1hUBteOSyJvAY7Ob6gHj8HcJTeXcc-bMqwEdg8g6VboXPzMOHgd-7oaIfnuxLMylKvUIegU~ULer4CBiJkqZnfo0Q6U1i4clzrKX6FIumvUVN2VxEEsham7ZRyFLFPetuYN-64GA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939815\/zoi260177f2_1775667484.11404.png?Expires=1779317431&amp;Signature=JYNC7rxi-qIc~IIMGPLXdoW8SxKXZALnUSiHHIgYCYYZMfzpXaWiZ4C4oNyBvLXDwpTD3iNhRUafw4JlP~TbgtBcKzcRKxXUQ1xyQPvM5toVTWOkUxUKChB2LbEOU5eCFvDUJsXvF4JxKXr98jysYPguRknqtiPWlMVwZ0Yildq6tOjwgPF9kkOiFFwbHSp~zc3co1f-sJ6rZNkp8LxUXfN4vwJGVjWnzgztwjWx-8GatvdAvp-PFHSY6bjk9PcxV4ZFsXkk3tki4eU31ZjxzdFMCWkFTZNZkz7vSns8M1Co1EkMahtKg9VFNRT4tsh5CJNE0eSIsK7RZnFqVV87nA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939815\/zoi260177t1_1775667484.09404.png?Expires=1779317431&amp;Signature=y5iHZD2lQQmr5QLaS-Qzv1bv47w81gbJd0013S1pF-TC5Cs11EMg~aFCOB8arFL~Hnw29IGH22JsvQuyt2Ve-nEO9JXYkIFXBlEB9GvDbLSnVmdu7XEauF-6Uf~92SWawtbHdHdfS0BLX-LNr8pVP0UuCE0z51dtWYnkpFg4mdMQw2AZOnXcDH7QitvrwrWLwBlomYvgAm8VRfX2m9-7fYMgqNIK5vXMd4OkZCddBLDxcMwTLD6B8fKiMkNJ~lvv-rDsn5jVKXD-vlsid0ftq-m5ehBPAaOMG9P8MqyAlQDg-AbUp3rSlYy91dEpvFA~U9oIrUsguQF3e3ayxXgwjA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939815\/zoi260177t2_1775667484.10403.png?Expires=1779317431&amp;Signature=H8LPOj2ZmzjgvQ623bh~qSAr66L8v-0hDAH93204Y6UhskSDnS1f0a0wzMNJX3~kG1SrosgBgBGv-BhvnpkYsuC0D45JYQlsViLeCXgYTmcl9sq~54C6mmfAK0Wmck3FpAClkxZiLq88WrWCtYie4G~gZKwhNkMcyCF~wyZoaMDG4O4A0AkwgLKiBi08ge7fu-cA5qFWSro4BKDbk0cSBHejJTlqsVoUMICf9Y9oiLh96MAYeTWBMmpe6wEzc~RvvHs1TJKbv-zeDSD7nqcaeuDZSSAwt~ZARhgHD-RYAKeo3TZzrGL4s46VgV9lxSgs-Wg4CddqZ0baQymkYGU7KA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939815\/zoi260177t3_1775667484.14404.png?Expires=1779317431&amp;Signature=Ew5s1P4eplSFL4gW17nfQMRp2W5WgeUV~fWLOIcUvgoIoSZcK~3Q2BmQngS4OtAZIVk~AucV-oImotsrzqy9JeZME3NIED~SDfMcdd2ktpOdUXbVzZK7pv~xX-HrSeAHldaeAtT0bZ2T5eqNzxX4jch2Xo910JT4FI~QI1zjCjv7K35-wlAU4Iu6z7wc2yXXBKl4AgrwTApX-bXO1W0zyEvSOKTBmUVYtSPgWFIqkmtYAQuf3y7m8lJSQVfvf~c9V-YWa-VzgbrLaTpb~MlJDqoCqkH7s0GM1jVK43CJI1keXNJdDOfjDxu3c8hQJRQgXEolIVRpMvROa55-NtvpjQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<p><strong>Conclusions and Relevance<\/strong>&nbsp;&nbsp;In this randomized clinical trial, CAD-assisted colonoscopy met noninferiority criteria for adenoma detection. Superiority was not statistically significant overall, with significant improvements limited to the exploratory FIT-positive subgroup, driven largely by diminutive adenomas. CAD also increased intensive surveillance assignments. The incremental benefit of CAD in reducing interval cancer risk requires further investigation.<\/p>\n\n\n\n<p><strong>Trial Registration<\/strong>&nbsp;&nbsp;ClinicalTrials.gov Identifier:&nbsp;<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT03842059\">NCT03842059<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original Investigation&nbsp; Gastroenterology and Hepat [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32,23],"tags":[],"_links":{"self":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/30700"}],"collection":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30700"}],"version-history":[{"count":1,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/30700\/revisions"}],"predecessor-version":[{"id":30701,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/30700\/revisions\/30701"}],"wp:attachment":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}